The concept of adipose tissue as an organ unto itself represents a new medical construct; already differences in the volume of perirenal fat around a tumor-bearing kidney have been described. We hypothesized that renal calculi may have similar impact on perirenal fat or alternatively abnormalities in urinary metabolites may be the result of perirenal fat affecting renal metabolism and subsequent stone formation. Accordingly, we conducted a study utilizing three-dimensional imaging software to evaluate perirenal fat volume (PFV) in patients with nephrolithiasis. Among 40 patients with a history of unilateral nephrolithiasis who underwent percutaneous nephrolithotomy between 2010 and 2016, the following data were acquired: body mass index, past medical history, stone characteristics and composition (i.e., calcium oxalate, calcium phosphate, uric acid, and struvite calculi). In addition, patients were stratified by dominant stone composition (≥ 50% fraction). Bilateral PFV measurements were obtained using the preoperative computed tomography scan and specialized three-dimensional imaging software. The PFV of stone-bearing kidneys was significantly greater than non-stone-bearing kidneys (397.3 and 323 cc, respectively; p = 0.004), with the PFV difference in patients with CO-dominant stone-bearing kidneys reaching statistical significance (p = 0.003). Subgroup analysis showed greater PFV surrounding the stone-bearing kidney irrespective of gender (p = 0.03), with male patients possessing significantly greater stone-bearing (p = 0.01) and bilateral PFV (p = 0.01) compared to females. No significant correlations were found between PFV and stone volume or stone density. The PFV of calcium oxalate stone-bearing kidneys is significantly greater than non-stone-bearing kidneys for both male and female patients with nephrolithiasis.
Introduction
Obesity has been studied extensively as a risk factor for nephrolithiasis [1] . In recent years, the prevalence of obesity and kidney stone disease in the United States has risen to 36.5 and 8.8%, respectively [2, 3] . Although lifestyle and dietary abnormalities contribute to the formation of calculi, metabolic changes in urine composition in the setting of insulin resistance and the onset of diabetes mellitus have also been suggested as formidable lithogenic contributors [4, 5] . Moreover, findings in the literature suggest that nephrolithiasis is a common finding among individuals with metabolic syndrome [6, 7] .
The link between obesity and kidney stone disease was postulated in large observational studies that identified patients with nephrolithiasis as also often having a large body habitus [8] . Central adiposity provides a clinical index of adipose tissue surrounding the viscera and can predict the development of pathologic sequelae [9, 10] .
The concept of visceral fat as an organ system unto itself has recently come into the medical consciousness. Indeed, variability in perirenal visceral adipose tissue was identified in kidneys affected by renal cell carcinoma in 2012 [11] . To our knowledge, to date, the volumetric differences in perirenal fat have not been evaluated in patients with nephrolithiasis. Accordingly, we elected to study the possible relationship between perirenal fat volume (PFV) and the formation of renal calculi. Herein, we present findings from a retrospective evaluation of adipose tissue surrounding the kidney in patients with previously unoperated unilateral nephrolithiasis.
Methods

Retrospective review
Retrospective data from 97 patients with a unilateral renal calculus who underwent computed tomography (CT) scanning at UC Irvine and proceeded to have a percutaneous nephrolithotomy (PCNL) by two experienced 
Measurement of perirenal fat volume
PFV measurements of the stone-bearing and non-stonebearing kidney were performed by radiologists under the supervision of senior faculty. The most CT study prior to PCNL was used to measure PFV. Three-dimensional imaging software (Vitrea® Advanced Visualization Software, Vital Images Inc., Minnetonka, MN) was used to measure the perirenal fat bilaterally according to the visible boundaries of Gerota's fascia on imaging. The adrenal glands, kidneys, and renal hilar structures were subtracted from the surrounding perirenal fat to obtain the calculated PFV (cc), HU of the PFV, and a three-dimensional rendering of the volumetric measurement (Fig. 1) . 
Statistical analysis
Continuous variables were summarized with descriptive statistics and categorical variables were summarized with frequency and percentage. Paired sample t tests were performed for comparisons of unilateral and bilateral PFV. Pearson's correlation coefficient was computed for analysis of bilateral PFV and stone features. Statistical significance was defined as p ≤ 0.05.
Results
Forty patients met inclusion criteria. Twenty-four female and 16 male patients had a BMI of 32 ± 9.4 and 28.2 ± 6.7 kg/ m 2 , respectively. There was no significant difference in BMI with respect to gender (p = 0.191). Sixteen patients (39%) had DM and 26 patients (65%) had a history of recurrent ipsilateral nephrolithiasis (Table 1) . A total of 14 renal pelvic, eight calyceal, and 18 staghorn calculi were treated with PCNL. No significant correlation was found between stonebearing PFV and stone diameter, volume, or density.
In general, stone-bearing kidney PFV was significantly greater than non-stone-bearing kidney PFV (397.3 vs. 323 cc, respectively, p = 0.004). Stone-bearing PFV was also significantly greater after stratifying patients according to gender (p < 0.05) ( Table 2 ). In comparison to female patients, male patients had significantly more stone-bearing kidney PFV (545.4 vs. 271.4 cc, p = 0.009), and total (i.e., bilateral) PFV (978.8 vs. 500.4 cc, p = 0.01). A positive trend was observed between total PFV and age (r = 0.29, p = 0.146) (Fig. 2) , and total PFV and BMI (r = 0.23, p = 0.074) (Fig. 3) . In addition, the HU of stone-bearing kidney PFV was significantly greater than non-stone-bearing kidney PFV (− 79.8 vs. − 88.3 HU, respectively, p = 0.023).
The differences in PFV according to patient co-morbidities are shown in Table 2 . There was no difference detected between stone-bearing and non-stone-bearing PFV in diabetic patients or among patients with diabetes compared to non-diabetic patients. Furthermore, there were no differences in stone-bearing PFV in patients with DM compared to those without DM or when accounting for BMI in diabetic compared to non-diabetic patients in the study. Of interest, a history of recurrent ipsilateral nephrolithiasis trended toward greater stone-bearing kidney PFV compared to patients with newly diagnosed renal calculi (445.2 vs. 298.7 cc, respectively, p = 0.07).
After review of the postoperative stone analyses, there were 19 patients with CO-dominant calculi (79% of patients with calcium oxalate monohydrate dominant and 21% with calcium oxalate dihydrate dominant calculi), nine patients with CP-dominant calculi (carbonate apatite), ten patients with UA-dominant calculi, and two patients with struvite calculi (Table 2) . Among the dominant stone compositions, the difference between the stone-bearing and non-stone-bearing kidney PFV for patients with CO-dominant calculi was significant (336.08 vs. 272.2 cc, p = 0.003). Interestingly, the BMI of patients with CO-dominant calculi was significantly less than patients with CP-or UA-dominant calculi (p = 0.024). No other differences in BMI were found among patients stratified by their dominant stone composition.
Discussion
The implications of excess visceral adipose tissue have been documented in renal and systemic disease processes such as chronic kidney disease and hypertension. However, the role of adipose tissue bounded by Gerota's fascia in the retroperitoneum and the extent as to its specific involvement in renal disease is an area of limited study. Although abdominal adiposity in general has been associated with the development of chronic kidney disease [13] , studies have also shown an increased risk of nephropathy and hypertension with an accumulation of adipose tissue specifically in the renal sinus [14, 15] . Importantly, the aforementioned findings held true after adjusting for the patient's BMI and total visceral adipose tissue. Clinical observational studies in humans and animal models of diet-induced obesity hypothesize that renal sinus lipomatosis results in renal vein and lymphatic compression at the hilum from excess adipose tissue, which increases renal interstitial pressure, the reabsorption of sodium, and the risk of hypertension [16, 17] . Increases in intra-abdominal pressure subsequent to visceral fat accumulation are also thought to act synergistically with renal sinus lipomatosis, further exacerbating the mass effect of fat within the renal hilum to obstruct the outflow of blood, lymph, and urine [17] . These findings suggest that perirenal fat accumulation can affect the filtration and reabsorption processes in the kidney, predisposing filtrate to abnormalities in sodium balance. Considering that our PFV measurement calculated all adipose tissue bounded by Gerota's fascia it remains to be determined if the fat content of the renal sinus contributed to our findings, as the induction of inflammatory-based change in the kidney may have implicated the formation of renal calculi. In addition to the hypothesis of adipose tissue surrounding the renal hilum causing mass effect, the biochemical interactions between perirenal fat and the kidney are also thought to be possible contributors to renal disease. In a study by Ma et al., seven pigs fed with 16-week of a high-fat/ high-carbohydrate diet demonstrated a significant increase in weight, systolic blood pressure, and PFV compared to those fed with an unmodified diet [18] . Ex vivo samples of the renal arteries from the experimental and control swine were then incubated with perirenal fat tissue from pigs fed with the aforementioned diet. Histologic examination of the renal vasculature specimens demonstrated marked inflammatory cell infiltrate, an increase in reactive oxygen species, and elevated tumor necrosis factor-alpha levels, resulting in a damaged and dysfunctional renal endothelium [18] . Hou et al. found that perirenal fat was associated with microalbuminuria in rats fed with a high-fat diet; indeed, further analysis revealed renal endothelial dysfunction and hormonal induction of inflammatory pathways increased levels of glomerular reactive oxygen species [19] . Endothelial injury is a fundamental etiology found in patients with chronic kidney disease and may lead to urolithiasis formation [20, 21] . The potential for similar pathologic hormonal signaling in human renal units has yet to be studied.
Adipose tissue is distributed into two metabolically and hormonally distinct body compartments, namely subcutaneous adipose tissue and visceral adipose tissue [22, 23] . Visceral or central obesity refers clinically to visceral adipose tissue accumulation, which has been distinguished as a significant independent risk factor for metabolic syndrome and cardiovascular disease [24] . Although BMI is often used as a clinical measure of morbidity, other metrics of visceral adipose tissue, such as waist-to-hip circumference, have been shown to be better indicators of all-cause mortality than BMI [25] . Similarly, we could find no statistically significant difference between BMI and bilateral PFV; indeed, greater PFV of the stone-bearing kidney occurred regardless of BMI (i.e., in both obese and non-obese patients). This suggests that BMI may not be an accurate predictor PFV, nor an appropriate measure of the risk of nephrolithiasis.
We noted differences in perirenal fat with respect to gender, with male patients bearing significantly more stonebearing and total PFV compared to females. Similarly, Favre et al. measured PFV by manually outlining and summating abdominal CT slices of perirenal fat, which demonstrated significantly less adipose tissue bilaterally in women compared to men [26] . The discrepancy in PFV between males and females has been hypothesized to be a result of ectopic fat storage occurring largely in the subcutaneous tissue in women compared to storage in the viscera in men [27] . Furthermore, the increased storage of visceral adipose tissue in male kidneys may contribute to the possible gross and physiological effects of perirenal fat on the kidney and the greater risk of nephrolithiasis in men [3] .
An unexpected finding in our study was a significant difference in the HU of the perirenal fat itself between the stone-bearing and non-stone-bearing kidney PFV (− 79.8 and − 88.3 HU, respectively). Large depots of metabolically active brown adipose tissue have previously been noted to surround the kidney [28] . A study by Bata et al. reported that activation of brown adipose tissue on positron emission tomography-computed tomography (PET-CT) also corresponded to a positive change in HU, suggesting that higher HU may characterize metabolically active brown adipose tissue [29] . Therefore, the positive difference in HU of the stone-bearing PFV may signify increased metabolic activity and suggests the possibility of a unique physiologic character of the perirenal fat in patients with unilateral nephrolithiasis. Whether this occurs prior to stone formation and thus affects urinary metabolism or after a calculus is already present (i.e., cause or effect) is a topic for further exploration.
In our study, patients specifically with CO-dominant calculi had significantly greater stone-bearing kidney PFV compared to the contralateral non-stone-bearing PFV. This is of interest in that CO-dominant calculi, as opposed to struvite or uric acid uroliths, form within the papillae and on Randall's plaques. In addition, calcium oxalate crystals are a proven source of inflammation within the tubules [30] . As such, one might hypothesize that the CO-dominant stone represents a pan-renal inflammatory condition that may impact PFV. Further support of this hypothesis comes from the lack of difference in PFV in patients with uric acid as well as struvite stone; this is perhaps somewhat surprising given the association of the former stone type with obesity and metabolic syndrome.
There are few limitations in this study in addition to its retrospective nature. First, the number of patients without calcium oxalate stones was markedly small, limiting our ability to perform subcategory analysis and warrants a further larger study of other stone types. Second, although our findings suggest that perirenal fat accumulation may play a role in the development of calcium oxalate-based nephrolithiasis, we did not evaluate if baseline differences in PFV exist between the right and left kidney in patients who have no history of stone disease or in diabetic patients who are presently without a history of renal calculi. Similarly, we did not compartmentalize the perirenal fat into the fat contained within Gerota's fascia vs. perisinus fat; both of these compartments were combined in the final analysis. Finally, the study includes a specific population of patients with large renal calculi undergoing PCNL and these findings may not be generalized to all stone formers.
Conclusion
Radiographic increases in PFV exist in patients with unilateral calcium oxalate nephrolithiasis. This difference was not observed in patients with calcium phosphate apatite, uric acid or struvite urolithiasis albeit with a small sample size. Future studies with a larger sample size of patients are required to further elucidate the role of perirenal fat volume in patients with nephrolithiasis.
